Difference between revisions of "Workshop on Clinical Trial Ontology"

From NCBO Wiki
Jump to navigation Jump to search
m
 
(52 intermediate revisions by 6 users not shown)
Line 1: Line 1:
 
== '''General Information''' ==
 
== '''General Information''' ==
 
'''<big>REGISTRATION FOR THIS EVENT IS NOW CLOSED!</big>'''
 
  
 
The National Center for Biomedical Ontology will host a two-day workshop focused on the Ontology of Clinical Trials. The workshop will take place on May 16-17, 2007 at the NIH Campus in Bethesda, MD.  
 
The National Center for Biomedical Ontology will host a two-day workshop focused on the Ontology of Clinical Trials. The workshop will take place on May 16-17, 2007 at the NIH Campus in Bethesda, MD.  
Line 15: Line 13:
 
The aim of the workshop is to foster the creation and dissemination of a reference ontology (high-quality controlled structured vocabulary) for the annotation of the results of clinical trials.  
 
The aim of the workshop is to foster the creation and dissemination of a reference ontology (high-quality controlled structured vocabulary) for the annotation of the results of clinical trials.  
  
The Workshop will bring together representatives of all of the major groups involved in clinical trial informatics, design, execution, analysis and standardization, with the goal of achieving a broad consensus on the requirements which the ontology should address and on the most effective means of realizing these requirements.
+
The Workshop will bring together representatives of all of the major groups involved in clinical trial informatics, design, execution, analysis and standardization, with the goal of achieving a broad consensus on the requirements which the ontology should address and on the most effective means of realizing these requirements. It will address the potential uses of CTO, and methodology for CTO design and development.
  
== Goals of the Clinical Trial Ontology Initiative==
+
== '''Goals of the Clinical Trial Ontology Initiative''' ==
  
 
The proposed CTO should:
 
The proposed CTO should:
Line 23: Line 21:
 
(1) fully and faithfully capture the types of entities and relationships involved in clinical trials of any experimental design
 
(1) fully and faithfully capture the types of entities and relationships involved in clinical trials of any experimental design
  
(2) comprehend terms like: ''cohort, randomization, placebo, response, efficacy, control, protocol, null hypothesis, confidence interval, finding, biomarker, primary outcome, secondary outcome, intervention group, experimental design,'' etc., including also major relevant statistical terms and terms drawn from resources such as the CDISC [http://www.cdisc.org/glossary/clinicalterminologyv4.pdf glossary] and  
+
(2) comprehend terms like: ''cohort, randomization, placebo, response, efficacy, control, protocol, null hypothesis, confidence interval, finding, biomarker, primary outcome, secondary outcome, intervention group, confounder,'' etc., including also major relevant statistical terms and terms drawn from resources such as the CDISC [http://www.cdisc.org/glossary/clinicalterminologyv4.pdf glossary] and  
 
all terms needed for the task of meta-analysis of clinical trials;  
 
all terms needed for the task of meta-analysis of clinical trials;  
  
Line 38: Line 36:
 
-- the [http://rctbank.ucsf.edu/ontology/outline/index.htm RCT Schema] ontology used by the[http://rctbank.ucsf.edu/ Trial Bank Initiative]
 
-- the [http://rctbank.ucsf.edu/ontology/outline/index.htm RCT Schema] ontology used by the[http://rctbank.ucsf.edu/ Trial Bank Initiative]
  
(7) rest on a clear understanding of the relation between CTO and an epidemiology study ontology
+
(7) rest on a clear understanding of the relation between CTO and related ventures such as an epidemiology study ontology
  
(8) rest on a clear understanding of the relation between CTO and data-model-oriented initiatives such as CDISC and BRIDG.
+
(8) rest on a clear understanding of the relation between CTO and data-model-oriented initiatives such as CDISC and BRIDG
  
(9) meet the requirements of the [http://obofoundry.org OBO Foundry], and in particular support an adequate treatment of the distinction between ''types'' (''surgical intervention'', ''tumor'', ''human being'') and ''instances'' (Jane's oophorectomy, John's tumor, Fritz)
+
(9) be created through an open process, in which all interested parties can be involved.
  
== Agenda ==
+
== '''Agenda''' ==
  
'''''<big>PLEASE ALLOW AN EXTRA 30 MINUTES TO COMPLETE THE NIH SECURITY ADMISSION PROCESS</big>'''''
+
'''<big><u>Wednesday, May 16 - Building 45 (Natcher), Balcony A</u></big>'''
  
'''<big><u>Wednesday, May 16 - Building 45 (Natcher), Balcony A</u></big>'''
+
* 8:00am -- Registration & Continental Breakfast
  
 
'''Session 1 (Chair: Barry Smith)'''
 
'''Session 1 (Chair: Barry Smith)'''
 
* 8:00am -- Continental Breakfast & Registration
 
  
 
* 9:00am -- Carol Bean: ''Introduction''
 
* 9:00am -- Carol Bean: ''Introduction''
Line 58: Line 54:
 
* 9:10am -- Susan Shurin, Deputy Director of the National Heart Lung and Blood Institute: ''Welcome''
 
* 9:10am -- Susan Shurin, Deputy Director of the National Heart Lung and Blood Institute: ''Welcome''
  
* 9:20am -- Werner Ceusters: ''How to Build an Ontology''
+
* 9:20am -- Werner Ceusters: ''How to Build an Ontology'' [http://ontology.buffalo.edu/07/CTO/ceusters.ppt ppt]
  
 
* 10:00am -- Discussion
 
* 10:00am -- Discussion
 +
 +
* 10:15am -- Refreshment Break
  
 
'''Session 2 (Chair: Dave Parrish)'''
 
'''Session 2 (Chair: Dave Parrish)'''
  
* 10:15am -- Refreshment Break
+
* 10:30am -- Chris Mungall: ''The OBO Foundry'' [http://ontology.buffalo.edu/07/CTO/mungall.ppt ppt]
 
 
* 10:30am -- Chris Mungall: ''The OBO Foundry''
 
  
* 11:00am -- Jennifer Fostel: ''The Ontology for Biomedical Investigations''  
+
* 11:00am -- Jennifer Fostel: ''The Ontology for Biomedical Investigations'' [http://ontology.buffalo.edu/07/CTO/fostel.ppt ppt]
  
* 11:30am -- Richard Scheuermann: ''Introducing the Clinical Trial Ontology''
+
* 11:30am -- Richard Scheuermann: ''Introducing the Clinical Trial Ontology'' [http://ontology.buffalo.edu/07/CTO/scheuermann.ppt  ppt]
  
 
* 12:00pm -- Discussion
 
* 12:00pm -- Discussion
Line 78: Line 74:
 
'''Session 3 (Chair: Werner Ceusters)'''
 
'''Session 3 (Chair: Werner Ceusters)'''
  
* 1:30pm -- Ida Sim: ''The RCT Schema''  
+
* 1:30pm -- Ida Sim: ''The RCT Schema'' [http://ontology.buffalo.edu/07/CTO/sim.ppt  ppt]
  
 
* 2:00pm -- Amar Das: ''Epoch: An Ontological Framework for Clinical Trial Management''
 
* 2:00pm -- Amar Das: ''Epoch: An Ontological Framework for Clinical Trial Management''
 +
[http://ontology.buffalo.edu/07/CTO/Das.pdf ppt]
  
* 2:30pm -- Barry Smith: ''The Clinical Trial Ontology: Creating Consensus''  
+
* 2:30pm -- Barry Smith: ''The Clinical Trial Ontology: Creating Consensus'' [http://ontology.buffalo.edu/07/CTO/smith.ppt  ppt]
  
 
* 3:30pm -- Refreshment Break
 
* 3:30pm -- Refreshment Break
Line 93: Line 90:
 
'''<big><u>Thursday, May 17 - Building 31, Conference Room 10</u></big>'''
 
'''<big><u>Thursday, May 17 - Building 31, Conference Room 10</u></big>'''
  
* 8:00am -- Continental Breakfast & Registration
+
* 8:00am -- Registration & Continental Breakfast
  
'''Session 4 (Moderator: Richard Scheuermann)'''
+
'''Session 4 (Moderator: Jennifer Fostel)'''  
  
 
* 9:00am -- Building the Clinical Trial Ontology
 
* 9:00am -- Building the Clinical Trial Ontology
Line 104: Line 101:
  
 
* 11:00am -- Applying the Clinical Trial Ontology
 
* 11:00am -- Applying the Clinical Trial Ontology
 +
**Norbert Graf: ACGT's Clinical Trial Builder [http://ontology.buffalo.edu/07/CTO/graf.ppt ppt]
  
 
* 12:30pm -- Lunch Break
 
* 12:30pm -- Lunch Break
Line 109: Line 107:
 
'''Session 6 (Moderator: Richard Scheuermann)'''
 
'''Session 6 (Moderator: Richard Scheuermann)'''
  
* 1:30pm -- The Future of the Clinical Trial Ontology
+
* 1:30pm -- The Future of the Clinical Trial Ontology [[Media:CTO_Workshop_Day_2_RS_JL.doc]]
  
* 3:00pm -- Refreshments/Close
+
* 3:00pm -- Close
  
== NIH Security Regulations ==
+
== '''NIH Security Regulations''' ==
  
 
All visitor vehicles, including taxicabs, hotel and airport shuttles, delivery trucks and vans will be inspected before being allowed on campus. Visitors will be asked to show a form of government-issued photo identification (driver's license, passport, green card, etc.) and to state the purpose of their visit. Be sure to allow extra time for this vehicle inspection procedure. Employees and visitors should continue to wear their identification prominently at all times while on campus.
 
All visitor vehicles, including taxicabs, hotel and airport shuttles, delivery trucks and vans will be inspected before being allowed on campus. Visitors will be asked to show a form of government-issued photo identification (driver's license, passport, green card, etc.) and to state the purpose of their visit. Be sure to allow extra time for this vehicle inspection procedure. Employees and visitors should continue to wear their identification prominently at all times while on campus.
Line 139: Line 137:
 
Visitors arriving by bus will be dropped off at the NIH/Medical Center Metro stop at Rockville Pike and South Drive. Patients and visitors on official business can then ride the Campus Shuttle to the Clinical Center and other designated shuttle stops on the campus.
 
Visitors arriving by bus will be dropped off at the NIH/Medical Center Metro stop at Rockville Pike and South Drive. Patients and visitors on official business can then ride the Campus Shuttle to the Clinical Center and other designated shuttle stops on the campus.
  
== Registered Participants ==
+
== '''Participants (Final)''' ==
  
Robert Arp -- NCBO, Buffalo, NY
+
Robert Arp -- NCBO, University at Buffalo
 
 
Pat Avery -- Digital Infuzion, Inc.
 
  
 
Elaine Ayres -- NIH / Clinical Center
 
Elaine Ayres -- NIH / Clinical Center
Line 167: Line 163:
 
Ling Chin -- National Institute on Deafness and Other Communication Disorders (NIDCD) / NIH
 
Ling Chin -- National Institute on Deafness and Other Communication Disorders (NIDCD) / NIH
  
Christopher G. Chute -- NCBO, Mayo Clinic, Rochester, MN
+
In Hye Cho -- National Library of Medicine (NLM) / NIH
 +
 
 +
Christopher G. Chute -- NCBO, Mayo Clinic
 +
 
 +
Kevin Clany -- Invitrogen Corp.
  
Christian Cocos -- IFOMIS, Saarbrücken, Germany
+
Christian Cocos -- IFOMIS (Saarbrücken, Germany)
  
 
Elaine Collier -- National Center for Research Resources (NCRR) / NIH
 
Elaine Collier -- National Center for Research Resources (NCRR) / NIH
  
Leo Cousineau -- Information Management Consultants, Reston, VA
+
Leo Cousineau -- Information Management Consultants (Reston, VA)
  
 
Lindsay Cowell -- Duke University Medical Center
 
Lindsay Cowell -- Duke University Medical Center
Line 184: Line 184:
  
 
Liju Fan -- Ontology Workshop, LLC
 
Liju Fan -- Ontology Workshop, LLC
 +
 +
Gabriele Feolo -- National Heart, Lung and Blood Institute (NHLBI) / NIH
  
 
Kerstin Forsberg -- AstraZeneca
 
Kerstin Forsberg -- AstraZeneca
Line 191: Line 193:
 
Douglas Fridsma -- University of Pittsburgh
 
Douglas Fridsma -- University of Pittsburgh
  
Charles P. Friedman -- NIH/CRIIT/NHLBI
+
Jane Fun -- Contractor, National Library of Medicine (NLM) / NIH
  
 
Louis J. Goldberg -- University at Buffalo
 
Louis J. Goldberg -- University at Buffalo
Line 197: Line 199:
 
Peter Good -- National Human Genome Research Institute (NHGRI) / NIH
 
Peter Good -- National Human Genome Research Institute (NHGRI) / NIH
  
Norbert Graf -- Clinic for Paediatric Oncology and Haematology, Saarland University, Homburg, Germany  
+
Norbert Graf -- Clinic for Paediatric Oncology and Haematology, Saarland University (Homburg, Germany)
  
 
Lakshmi M. Grama -- National Cancer Institute (NCI) / NIH
 
Lakshmi M. Grama -- National Cancer Institute (NCI) / NIH
  
Ted Grasela -- Cognigen Corporation, Amherst, NY
+
Ted Grasela -- Cognigen Corporation (Amherst, NY)
 
 
Patricia Haggerty -- National Heart, Lung and Blood Institute (NHLBI) / NIH
 
  
 
Herb Hagler -- University of Texas Southwestern Medical Center
 
Herb Hagler -- University of Texas Southwestern Medical Center
Line 212: Line 212:
  
 
Steve Harris -- Computing Laboratory, University of Oxford
 
Steve Harris -- Computing Laboratory, University of Oxford
 +
 +
Frank Hartel -- NCI Center for Bioinformatics / NIH
  
 
Calvin A. Johnson -- Center for Information Technology (CIT) / NIH
 
Calvin A. Johnson -- Center for Information Technology (CIT) / NIH
 +
 +
Heather A. Junkins -- CRIIT & NHLBI / NIH
 +
 +
Webster Kelsey -- Dept of Biomedical Informatics, University of Pittsburgh
  
 
Warren A. Kibbe -- Northwestern University
 
Warren A. Kibbe -- Northwestern University
  
 
Bron W. Kisler -- Clinical Data Interchange Standards Consortium (CDISC)
 
Bron W. Kisler -- Clinical Data Interchange Standards Consortium (CDISC)
 +
 +
George A. Komatsoulis -- NCI Center for Bioinformatics / NIH
 +
 +
Jennie Larkin -- National Heart, Lung and Blood Institute (NHLBI) / NIH
  
 
William Lau -- Center for Information Technology (CIT) / NIH
 
William Lau -- Center for Information Technology (CIT) / NIH
Line 227: Line 237:
 
Yuan Liu -- National Institute of Neurological Diseases and Stroke (NINDS) / NIH
 
Yuan Liu -- National Institute of Neurological Diseases and Stroke (NINDS) / NIH
  
Dan Lyman -- Information Management Consultants, Reston, VA
+
Yun Lu -- KAI Research, Inc.
 +
 
 +
Dan Lyman -- Information Management Consultants (Reston, VA)
 +
 
 +
Peter Lyster -- Center for Bioinformatics and Computational Biology, National Institute of General Medical Sciences (NIGMS) / NIH
 +
 
 +
Peter Maccallum -- CRUK Cambridge Research Institute, University of Cambridge
  
 
Charles Mead -- NCI/NIH, Center for Biomedical Informatics and Information Technology  
 
Charles Mead -- NCI/NIH, Center for Biomedical Informatics and Information Technology  
  
Ivan Montoya -- National Institute on Drug Abuse (NIDA) / NIH
+
Chris Mungall -- NCBO, Lawrence Berkeley National Laboratory
  
Chris Mungall -- Lawrence Berkeley National Laboratory, Berkeley, CA
+
Robert A. Musson -- National Heart, Lung and Blood Institute (NHLBI) / NIH
  
Robert A. Musson -- National Heart, Lung and Blood Institute (NHLBI) / NIH
+
Darren Natale -- Georgetown University Medical Center
  
 
Fabian Neuhaus -– National Institute of Standards and Technology (NIST)
 
Fabian Neuhaus -– National Institute of Standards and Technology (NIST)
  
Eric Neumann -- Teranode, Seattle, WA
+
Eric Neumann -- Teranode (Seattle, WA)
 +
 
 +
Eduardo Ortiz -- National Heart, Lung and Blood Institute (NHLBI) / NIH
  
 
Jeng-Jong Pan -- National Institute on Drug Abuse (NIDA) / NIH
 
Jeng-Jong Pan -- National Institute on Drug Abuse (NIDA) / NIH
  
Dave Parrish -- Immune Tolerance Network, Pittsburgh, PA
+
Dave Parrish -- Immune Tolerance Network (Pittsburgh, PA)
 
 
Ricardo Pietrobon -- Duke University Medical Center
 
  
 
George O. Redmond -- National Cancer Institute (NCI) / NIH
 
George O. Redmond -- National Cancer Institute (NCI) / NIH
  
Alexander Rosenthal -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH
+
Dianne M. Reeves -- National Cancer Institute, Center for Biomedical Informatics and Information Technology (formerly NCICB) / NIH
  
 
Alan Ruttenberg -- Science Commons (c/o MIT CSAIL)
 
Alan Ruttenberg -- Science Commons (c/o MIT CSAIL)
 
Laurie M. Ryan -- National Institute on Aging (NIA) / NIH
 
  
 
Jody Sachs -- National Center for Research Resources (NCRR) / NIH
 
Jody Sachs -- National Center for Research Resources (NCRR) / NIH
Line 267: Line 281:
 
Ida Sim -- Trial Bank, University of California at San Francisco Medical Center
 
Ida Sim -- Trial Bank, University of California at San Francisco Medical Center
  
Barry Smith -- NCBO, University at Buffalo, NY
+
Barry Smith -- NCBO, University at Buffalo
  
Ranjana Srivastava -- Information Management Consultants, Reston, VA
+
Ranjana Srivastava -- Information Management Consultants (Reston, VA)
  
 
Samson Tu -- Stanford University
 
Samson Tu -- Stanford University
Line 277: Line 291:
 
Chunhua Weng -- University of Pittsburgh
 
Chunhua Weng -- University of Pittsburgh
  
Trish Whetzel -- University of Pennsylvania
+
Rebecca Williams -- National Library of Medicine (NLM) / NIH
  
Rebecca Williams -- National Library of Medicine (NLM) / NIH
+
Ashley Xia -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH
  
Sandhya Xirasagar -- Information Management Consultants, Reston, VA
+
Sandhya Xirasagar -- Information Management Consultants (Reston, VA)
  
 
Alison Yao -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH
 
Alison Yao -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH
  
== Venue ==
+
Zhensheng Zhang -- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) / NIH
 +
 
 +
== '''Venue''' ==
  
 
Day 1: Balcony A, Building 45 (Natcher), NIH Campus, Bethesda, MD
 
Day 1: Balcony A, Building 45 (Natcher), NIH Campus, Bethesda, MD
Line 291: Line 307:
 
Day 2: Conference Room 10, Building 31, NIH Campus, Bethesda, MD
 
Day 2: Conference Room 10, Building 31, NIH Campus, Bethesda, MD
  
[http://www.nih.gov/about/visitor/index.htm Travel to NIH Campus]
+
A printable NIH Visitors Map can be found at: [http://parking.nih.gov/documents/visitorAccessMap.pdf NIH Visitors Map]
 +
 
 +
A printable schedule of shuttle service between area hotels and NIH can be found at:  [http://dtts.ors.od.nih.gov/documents/south_hotel_shuttles.pdf NIH Shuttles]
  
== Links ==
+
== '''Links''' ==
  
 
[http://www.bioontology.org/ncbo/faces/index.xhtml NCBO Bioportal]
 
[http://www.bioontology.org/ncbo/faces/index.xhtml NCBO Bioportal]
Line 321: Line 339:
 
The second half of this presentation pertains to the building of the Clinical Trial Ontology.
 
The second half of this presentation pertains to the building of the Clinical Trial Ontology.
  
== Preliminary Fragment of CTO (for illustration purposes only) ==
+
== '''Preliminary Fragment of CTO''' (for illustration purposes only) ==
  
 
[http://cto.googlecode.com/svn/trunk/CTO.owl Current OWL version]
 
[http://cto.googlecode.com/svn/trunk/CTO.owl Current OWL version]
  
 
[[Image:CTO.jpg]]
 
[[Image:CTO.jpg]]

Latest revision as of 10:38, 6 August 2008

General Information

The National Center for Biomedical Ontology will host a two-day workshop focused on the Ontology of Clinical Trials. The workshop will take place on May 16-17, 2007 at the NIH Campus in Bethesda, MD.

The meeting will be divided into two parts. Day 1 will be a public event consisting of presentations and panel discussions on the CTO and cognate initiatives. Day 2 will be a working meeting devoted to intense discussions of mature drafts of the CTO and to the creation of a strategy for its further development and testing.

The work of the NCBO is funded by the National Institutes of Health through the NIH Roadmap for Medical Research, Grant 1 U 54 HG004028. Information on the National Centers for Biomedical Computing can be found here.

We are grateful to the National Heart, Lung and Blood Institute for generous support for this meeting.

Aim of the Workshop

The aim of the workshop is to foster the creation and dissemination of a reference ontology (high-quality controlled structured vocabulary) for the annotation of the results of clinical trials.

The Workshop will bring together representatives of all of the major groups involved in clinical trial informatics, design, execution, analysis and standardization, with the goal of achieving a broad consensus on the requirements which the ontology should address and on the most effective means of realizing these requirements. It will address the potential uses of CTO, and methodology for CTO design and development.

Goals of the Clinical Trial Ontology Initiative

The proposed CTO should:

(1) fully and faithfully capture the types of entities and relationships involved in clinical trials of any experimental design

(2) comprehend terms like: cohort, randomization, placebo, response, efficacy, control, protocol, null hypothesis, confidence interval, finding, biomarker, primary outcome, secondary outcome, intervention group, confounder, etc., including also major relevant statistical terms and terms drawn from resources such as the CDISC glossary and all terms needed for the task of meta-analysis of clinical trials;

(3) organize these terms in a structured way, providing definitions and logical relations designed to enhance retrieval of, reasoning with, and integration of the data annotated in its terms.

(4) support trial bank interoperation

(5) form an integral part of the more comprehensive framework of the Ontology for Biomedical Investigations OBI, which itself forms part of the OBO Foundry

(6) draw on and seek maximal alignment with existing clinical trial ontologies, including:

-- the Epoch ontology used by the Immune Tolerance Network

-- the RCT Schema ontology used by theTrial Bank Initiative

(7) rest on a clear understanding of the relation between CTO and related ventures such as an epidemiology study ontology

(8) rest on a clear understanding of the relation between CTO and data-model-oriented initiatives such as CDISC and BRIDG

(9) be created through an open process, in which all interested parties can be involved.

Agenda

Wednesday, May 16 - Building 45 (Natcher), Balcony A

  • 8:00am -- Registration & Continental Breakfast

Session 1 (Chair: Barry Smith)

  • 9:00am -- Carol Bean: Introduction
  • 9:10am -- Susan Shurin, Deputy Director of the National Heart Lung and Blood Institute: Welcome
  • 9:20am -- Werner Ceusters: How to Build an Ontology ppt
  • 10:00am -- Discussion
  • 10:15am -- Refreshment Break

Session 2 (Chair: Dave Parrish)

  • 10:30am -- Chris Mungall: The OBO Foundry ppt
  • 11:00am -- Jennifer Fostel: The Ontology for Biomedical Investigations ppt
  • 11:30am -- Richard Scheuermann: Introducing the Clinical Trial Ontology ppt
  • 12:00pm -- Discussion
  • 12:30pm -- Lunch Break

Session 3 (Chair: Werner Ceusters)

  • 1:30pm -- Ida Sim: The RCT Schema ppt
  • 2:00pm -- Amar Das: Epoch: An Ontological Framework for Clinical Trial Management

ppt

  • 2:30pm -- Barry Smith: The Clinical Trial Ontology: Creating Consensus ppt
  • 3:30pm -- Refreshment Break
  • 4:00pm -- Discussion Session
  • 5:00pm -- Close


Thursday, May 17 - Building 31, Conference Room 10

  • 8:00am -- Registration & Continental Breakfast

Session 4 (Moderator: Jennifer Fostel)

  • 9:00am -- Building the Clinical Trial Ontology
  • 10:30am -- Refreshment Break

Session 5 (Moderator: Alan Ruttenberg)

  • 11:00am -- Applying the Clinical Trial Ontology
    • Norbert Graf: ACGT's Clinical Trial Builder ppt
  • 12:30pm -- Lunch Break

Session 6 (Moderator: Richard Scheuermann)

  • 3:00pm -- Close

NIH Security Regulations

All visitor vehicles, including taxicabs, hotel and airport shuttles, delivery trucks and vans will be inspected before being allowed on campus. Visitors will be asked to show a form of government-issued photo identification (driver's license, passport, green card, etc.) and to state the purpose of their visit. Be sure to allow extra time for this vehicle inspection procedure. Employees and visitors should continue to wear their identification prominently at all times while on campus.

Guards will remain at certain buildings to address specific program requirements such as sensitive research and safety concerns. At building entrances where guards are posted:

  • Visitors may be required to log in, wear a visitors pass and have an employee escort them through the building.
  • Visitors may be required to pass through a metal detector and have bags, backpacks or purses inspected or x-rayed as they enter buildings.

Security staff will be looking for and confiscating any suspicious or potentially dangerous materials. U.S. Code prohibits bringing any dangerous weapons onto Federal property, including anything with a blade longer than 2½ inches. Meeting participants may want to leave extra bags or personal materials at their hotel to minimize the time needed for inspection.

All visitors including patients, contractors, vendors and delivery persons must use the following entrances:

Rockville Pike at South Drive (Metro):

  • Open 24 hours - Inbound and Outbound traffic
  • Open to All Vehicles
  • Pedestrian Turnstiles Open for Employees
  • Gateway Center at Metro Open for Visitor Registration--this is where visitors check-in with security if they are not driving

Old Georgetown Road at Center Drive (This entrance is primarily for commercial vehicles and visitors):

  • 6am- 7pm -Inbound and Outbound Traffic
  • Open to Employee, Commercial and Visitor Vehicles
  • Pedestrian Turnstiles Open for Employees

Please note: Visitor parking is limited at NIH. Visitors are encouraged to use public transportation such as the Metrorail subway system which has a convenient stop (Medical Center) on the NIH campus.

Visitors arriving by bus will be dropped off at the NIH/Medical Center Metro stop at Rockville Pike and South Drive. Patients and visitors on official business can then ride the Campus Shuttle to the Clinical Center and other designated shuttle stops on the campus.

Participants (Final)

Robert Arp -- NCBO, University at Buffalo

Elaine Ayres -- NIH / Clinical Center

William Barrick -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH

Carol Bean -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Maureen Beanan -- National Center for Research Resources (NCRR) / NIH

Elmer Bernstam -- University of Texas Health Science Center at Houston

Olivier Bodenreider -- National Library of Medicine (NLM) / NIH

Olga Brazhnik -- National Center for Research Resources (NCRR) / NIH

Constantino Castillo -- The KEVRIC Company, Inc.

Werner Ceusters -- Ontology Research Group, University at Buffalo

Huey Cheung -- Center for Information Technology (CIT) / NIH

Ling Chin -- National Institute on Deafness and Other Communication Disorders (NIDCD) / NIH

In Hye Cho -- National Library of Medicine (NLM) / NIH

Christopher G. Chute -- NCBO, Mayo Clinic

Kevin Clany -- Invitrogen Corp.

Christian Cocos -- IFOMIS (Saarbrücken, Germany)

Elaine Collier -- National Center for Research Resources (NCRR) / NIH

Leo Cousineau -- Information Management Consultants (Reston, VA)

Lindsay Cowell -- Duke University Medical Center

Amar Das -- Stanford Medical Informatics

Kaushal Desai -- AstraZeneca

Stephen Dobson -- Pfizer Global Research and Development

Liju Fan -- Ontology Workshop, LLC

Gabriele Feolo -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Kerstin Forsberg -- AstraZeneca

Jennifer Fostel -- NIH/NIEHS

Douglas Fridsma -- University of Pittsburgh

Jane Fun -- Contractor, National Library of Medicine (NLM) / NIH

Louis J. Goldberg -- University at Buffalo

Peter Good -- National Human Genome Research Institute (NHGRI) / NIH

Norbert Graf -- Clinic for Paediatric Oncology and Haematology, Saarland University (Homburg, Germany)

Lakshmi M. Grama -- National Cancer Institute (NCI) / NIH

Ted Grasela -- Cognigen Corporation (Amherst, NY)

Herb Hagler -- University of Texas Southwestern Medical Center

Andrea Harabin -- National Heart, Lung and Blood Institute (NHLBI) / NIH

William Harlan -- Consultant, National Library of Medicine (NLM) / NIH

Steve Harris -- Computing Laboratory, University of Oxford

Frank Hartel -- NCI Center for Bioinformatics / NIH

Calvin A. Johnson -- Center for Information Technology (CIT) / NIH

Heather A. Junkins -- CRIIT & NHLBI / NIH

Webster Kelsey -- Dept of Biomedical Informatics, University of Pittsburgh

Warren A. Kibbe -- Northwestern University

Bron W. Kisler -- Clinical Data Interchange Standards Consortium (CDISC)

George A. Komatsoulis -- NCI Center for Bioinformatics / NIH

Jennie Larkin -- National Heart, Lung and Blood Institute (NHLBI) / NIH

William Lau -- Center for Information Technology (CIT) / NIH

Jamie Lee -- University of Texas Southwestern Medical Center at Dallas

Natasha Levenkov -- Rockefeller University

Yuan Liu -- National Institute of Neurological Diseases and Stroke (NINDS) / NIH

Yun Lu -- KAI Research, Inc.

Dan Lyman -- Information Management Consultants (Reston, VA)

Peter Lyster -- Center for Bioinformatics and Computational Biology, National Institute of General Medical Sciences (NIGMS) / NIH

Peter Maccallum -- CRUK Cambridge Research Institute, University of Cambridge

Charles Mead -- NCI/NIH, Center for Biomedical Informatics and Information Technology

Chris Mungall -- NCBO, Lawrence Berkeley National Laboratory

Robert A. Musson -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Darren Natale -- Georgetown University Medical Center

Fabian Neuhaus -– National Institute of Standards and Technology (NIST)

Eric Neumann -- Teranode (Seattle, WA)

Eduardo Ortiz -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Jeng-Jong Pan -- National Institute on Drug Abuse (NIDA) / NIH

Dave Parrish -- Immune Tolerance Network (Pittsburgh, PA)

George O. Redmond -- National Cancer Institute (NCI) / NIH

Dianne M. Reeves -- National Cancer Institute, Center for Biomedical Informatics and Information Technology (formerly NCICB) / NIH

Alan Ruttenberg -- Science Commons (c/o MIT CSAIL)

Jody Sachs -- National Center for Research Resources (NCRR) / NIH

Michael Sayre -- National Center for Research Resources (NCRR) / NIH

Richard Scheuermann -- University of Texas Southwestern Medical Center

Susan Shurin -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Hua-Chuan Sim -- National Library of Medicine (NLM) / NIH

Ida Sim -- Trial Bank, University of California at San Francisco Medical Center

Barry Smith -- NCBO, University at Buffalo

Ranjana Srivastava -- Information Management Consultants (Reston, VA)

Samson Tu -- Stanford University

Suresh Varghese -- Digital Infuzion, Inc.

Chunhua Weng -- University of Pittsburgh

Rebecca Williams -- National Library of Medicine (NLM) / NIH

Ashley Xia -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH

Sandhya Xirasagar -- Information Management Consultants (Reston, VA)

Alison Yao -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH

Zhensheng Zhang -- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) / NIH

Venue

Day 1: Balcony A, Building 45 (Natcher), NIH Campus, Bethesda, MD

Day 2: Conference Room 10, Building 31, NIH Campus, Bethesda, MD

A printable NIH Visitors Map can be found at: NIH Visitors Map

A printable schedule of shuttle service between area hotels and NIH can be found at: NIH Shuttles

Links

NCBO Bioportal

Open Biomedical Ontologies

OBO Foundry

Ontology for Biomedical Investigations

Trial Bank

Epoch Ontology

The ACGT Project: Advancing Clinico-Genomic Trials on Cancer

Clinical Trial Ontology Wiki

HCLS Ontology Task Force

A video introduction to ontologies by Barry Smith is available here:

  • Realmedia: rtsp://stream.buffalo.edu/shared/research/phismith/Stanford10-25-06/Tutorial.rm
  • Mediaplayer: rtsp://stream.buffalo.edu/shared/research/phismith/Stanford10-25-06/Tutorial.WMV

The second half of this presentation pertains to the building of the Clinical Trial Ontology.

Preliminary Fragment of CTO (for illustration purposes only)

Current OWL version

CTO.jpg